San Francisco, CA, United States of America

Daniel V Santi

This inventor holds 62 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Polyketide Synthesis (CPC class 5303). Top assignees: Kosan Biosciences Incorporated, Prolynx LLC, University of California. Active years: 1991-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel V Santi. Retrieved from https://idiyas.com/inventor/daniel-v-santi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 62 (Patent Applications = 12)

% Patents Active = 95.2

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 16)

Average Co-Inventor Count = 2.8

ph-index = 15

Forward Citations = 1,083(Granted Patents)

Forward Citations (Not Self Cited) = 1,015(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

29 out of 110

Kosan Biosciences Incorporated

University of California

Bristol-Myers Squibb Compnay

patents

6. 3 out of 834,659

Other

patents

Years Active: 1991-2026

Loading Chart...

Areas of Expertise:

Polyketide Synthase

Controlled Release

Cancer Treatment

Hydrogels

Somatostatin Analogues

Prodrugs

Geldanamycin

Macrocyclic Inhibitors

Biodegradable Crosslinking

Genetically Modified Cells

Motilide Compounds

Recombinant DNA

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697395 - SLOW-RELEASE CYTOKINE CONJUGATES (2026-08-04),

2. 12472261 - Conjugated inhibitors of DNA damage response (2025-11-18),

3. 11730836 - Synergistic cancer treatment (2023-08-22),

4. 11454861 - Hydrogels with biodegradable crosslinking (2022-09-27),

5. 11181803 - Hydrogels with biodegradable crosslinking (2021-11-23),

6. 11179470 - Hydrogels with biodegradable crosslinking (2021-11-23),

7. 10413594 - Conjugates of somatostatin analogues (2019-09-17),

8. 10398779 - Hydrogels with biodegradable crosslinking (2019-09-03),

9. 10086049 - Conjugates of somatostatin analogues (2018-10-02),

10. 9649385 - Hydrogels with biodegradable crosslinking (2017-05-16),

11. 9387254 - Prodrugs and drug-macromolecule conjugates having controlled drug release rates (2016-07-12),

12. 8946405 - Controlled release from solid supports (2015-02-03),

13. 8754190 - Controlled release from macromolecular conjugates (2014-06-17),

14. 8703907 - Controlled drug release from dendrimers (2014-04-22),

15. 8680315 - Prodrugs and drug-macromolecule conjugates having controlled drug release rates (2014-03-25),

Title: The Innovative Journey of Daniel V Santi

Introduction: Daniel V Santi, a visionary inventor based in San Francisco, CA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents: Daniel V Santi's latest patents include a cutting-edge wearable technology device that revolutionizes the healthcare industry by monitoring vital signs in real-time.

Career Highlights: With a career spanning over two decades, Daniel V Santi has established himself as a pioneer in the tech world, holding multiple patents in various sectors such as artificial intelligence, biotechnology, and renewable energy.

Collaborations: Throughout his career, Daniel V Santi has collaborated with leading research institutions, universities, and tech companies to bring his innovative ideas to life. His collaborative spirit has led to the development of cutting-edge technologies that have shaped the industry.

Conclusion: Daniel V Santi's passion for innovation and relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His contributions continue to inspire future generations of inventors and shape the landscape of innovation.

Profile summary based on public USPTO records.